Inventiva IVEVF
NASDAQ IVEVF
$3.59 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Inventiva (IVEVF) Profit After Tax (2019 - 2023)

Inventiva (IVEVF) posted Profit After Tax of -$945751.2 for Q4 2023, up 96.85% on a QoQ basis from -$30.1 million in Q4 2022, and up 96.85% year-over-year from -$480432.6 in Q4 2022.

Analysis

Inventiva (IVEVF) Profit After Tax (2019 - 2023) Analysis & Trends

Inventiva has reported Profit After Tax for 5 years, with the latest figure at -$945751.2 in Q4 2023.

  • On a quarterly basis, Profit After Tax rose 96.85% year-over-year to -$945751.2 in Q4 2023; TTM through Dec 2023 was -$58.9 million, a 39.93% increase from a year earlier, with the FY2025 full-year figure at $412.2 million, up 109.42% from the prior year.
  • Profit After Tax was -$945751.2 for Q4 2023 at Inventiva, up from -$30.1 million in the prior quarter.
  • The five-year high for Profit After Tax was -$945751.2 in Q4 2023, with the low at -$40.1 million in Q4 2020.
  • Average Profit After Tax over 5 years is -$18.7 million, with a median of -$13.9 million recorded in 2021.
  • The sharpest annual moves came in 2021 and 2023: Profit After Tax sank 76.4% in 2021, then jumped 96.85% in 2023.
  • Over 5 years, Profit After Tax stood at -$33.4 million in 2019, then slipped by 19.84% to -$40.1 million in 2020, then soared by 57.05% to -$17.2 million in 2021, then tumbled by 74.62% to -$30.1 million in 2022, then surged by 96.85% to -$945751.2 in 2023.
  • The last three Profit After Tax figures came in at -$945751.2 (Q4 2023), -$30.1 million (Q4 2022), and -$17.2 million (Q2 2021), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Johnson & Johnson 646.53 Bn 625.77 Bn 17.26 Bn 5.53 Bn
2 AbbVie 442.27 Bn 435.70 Bn 12.70 Bn 3.62 Bn
3 Merck 366.81 Bn 359.67 Bn 12.21 Bn -1.34 Bn
4 Novartis Ag 266.82 Bn 259.13 Bn 11.24 Bn 3.26 Bn
5 Pfizer 159.37 Bn 147.67 Bn 10.94 Bn -248.00 Mn
6 Sanofi 52.46 Bn 45.08 Bn 10.79 Bn 438.21 Mn
7 Revolution Medicines 44.12 Bn 44.12 Bn - -644.37 Mn
8 Incyte 25.49 Bn 20.95 Bn 1.57 Bn 585.61 Mn
9 United Therapeutics 21.55 Bn 18.89 Bn 683.80 Mn 333.00 Mn
10 Inventiva 693.72 Mn 693.72 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -945,751.18
Dec 31, 2022 -30.06 Mn
Jun 30, 2021 -17.22 Mn
Mar 31, 2021 -10.66 Mn
Dec 31, 2020 -40.08 Mn
Jun 30, 2020 -9.76 Mn
Mar 31, 2020 -7.50 Mn
Dec 31, 2019 -33.45 Mn